Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629

INTRODUCTION: Pembrolizumab provided durable responses and acceptable safety in recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC) in the KEYNOTE-629 study. In this elderly, fragile population with disfiguring tumours, preservation of health-related quality of life (HRQoL) is cri...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Brett G. M., Mendoza, Rene Gonzalez, Basset-Seguin, Nicole, Vornicova, Olga, Schachter, Jacob, Joshi, Abhishek, Meyer, Nicolas, Grange, Florent, Piulats, Josep M., Bauman, Jessica R., Chirovsky, Diana, Zhang, Pingye, Gumuscu, Burak, Swaby, Ramona F., Grob, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484388/
https://www.ncbi.nlm.nih.gov/pubmed/34558040
http://dx.doi.org/10.1007/s13555-021-00598-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484388/
https://www.ncbi.nlm.nih.gov/pubmed/34558040
http://dx.doi.org/10.1007/s13555-021-00598-6

Ejemplares similares